“Final Report of a Phase II Trial of Nimotuzumab in the Treatment of Refractory and Relapsed High-Grade Gliomas in Children and Adolescents”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 1, no. 6, June 2009, https://doi.org/10.4081/hmr.v1i6.675.